4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001209191-23-056486
President and CFO sold 8,000 shares at an average $51.13 ($409,063)
- President and CFO acquired 8,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GUGGENHIME ANDREW President and CFO | 2023-11-20 | Option exercise 10b5-1 | +8,000 | $5.35 | $42,800 | 87,474 | D |
| GUGGENHIME ANDREW President and CFO | 2023-11-20 | Sale 10b5-1 | −7,876 | $51.12 | $402,621 | 79,598 | D |
| GUGGENHIME ANDREW President and CFO | 2023-11-20 | Sale 10b5-1 | −124 | $51.95 | $6,442 | 79,474 | D |
| Derivatives | |||||||
| GUGGENHIME ANDREW President and CFO | 2023-11-20 | Option exercise · Stock Option (right to buy) 10b5-1 | −8,000 | 414,827 | D | ||
| Open-market sales · 8,000 sh · avg $51.13 · $409,063 | |||||||
Loading xslF345X05/doc4.xml…